Maria Arranz, Ph.D.
Affiliations: | Institute of Psychiatry, University of London, London, England, United Kingdom |
Area:
Pharmacogenetics of antipsychotic drug responseGoogle:
"Maria Arranz"Mean distance: 19.94 (cluster 51)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Arranz MJ, Salazar J, Hernández MH. (2020) Pharmacogenetics of antipsychotics: Clinical utility and implementation. Behavioural Brain Research. 113058 |
| Catalán R, González-Rodríguez A, Arranz M, et al. (2016) Impact of nicotine consumption on antipsychotic response based on genetic variants of cytochrome P450 2D6 and multi-drug resistance 1 C3435T in schizophrenia European Neuropsychopharmacology. 26 |
| Mitjans M, Catalán R, Vázquez M, et al. (2015) Hypothalamic-pituitary-adrenal system, neurotrophic factors and clozapine response: association with FKBP5 and NTRK2 genes. Pharmacogenetics and Genomics. 25: 274-7 |
| Bramon E, et al. (2014) A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biological Psychiatry. 75: 386-97 |
| Ripke S, O'Dushlaine C, Chambert K, et al. (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genetics. 45: 1150-9 |
| Shaikh M, Hall MH, Schulze K, et al. (2013) Effect of DISC1 on the P300 waveform in psychosis. Schizophrenia Bulletin. 39: 161-7 |
| Prata DP, Gafoor R, Kay V, et al. (2012) Dopaminergic genes influence early response to atypical antipsychotics in patients with first presentation of psychosis. Journal of Clinical Psychopharmacology. 32: 566-9 |
| Munro J, Skrobot O, Sanyoura M, et al. (2012) Relaxin polymorphisms associated with metabolic disturbance in patients treated with antipsychotics. Journal of Psychopharmacology (Oxford, England). 26: 374-9 |
| Arranz MJ, Munro JC. (2011) Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia. Expert Review of Clinical Pharmacology. 4: 389-405 |
| Arranz MJ, Rivera M, Munro JC. (2011) Pharmacogenetics of response to antipsychotics in patients with schizophrenia. Cns Drugs. 25: 933-69 |